When you have surgery at home, you assume the implant in your body was approved by the FDA. When you have surgery abroad, a different regulatory body approved it. That does not make it unsafe, but it means you need to understand what that approval process actually required.
The Four Major Regulatory Systems
| Regulator | Country/Region | What It Covers | Classification Tiers | Pre-Market Requirement |
|---|---|---|---|---|
| FDA | United States | All medical devices sold in the US | Class I (low risk) to Class III (high risk) | 510(k) clearance, De Novo, or PMA |
| INVIMA | Colombia | All medical devices sold in Colombia | Class I to Class III (mirrors FDA tiers) | Registro Sanitario (health registration) |
| COFEPRIS | Mexico | All medical devices sold in Mexico | Class I to Class III | Registro Sanitario + technical dossier |
| CE Mark | European Union | Devices sold in the EU/EEA | Class I to Class III (EU MDR) | Conformity assessment by Notified Body |
FDA: The Baseline Most Patients Know
The FDA classifies devices into three risk tiers. Class I (tongue depressors, bandages) requires general controls only. Class II (most surgical instruments, orthopedic implants) requires 510(k) clearance, demonstrating the device is substantially equivalent to a legally marketed predicate device. Class III (heart valves, implantable defibrillators) requires a Pre-Market Approval (PMA) with clinical data.
The important nuance: 510(k) clearance is not the same as approval. It means the FDA agreed the device is substantially equivalent to something already on the market. It does not require new clinical trials for Class II devices. PMA (Class III) requires clinical evidence. Most joint implants, breast implants, and IOLs go through PMA or a more rigorous pathway.
INVIMA: Colombia's Regulator
INVIMA operates a risk-based classification system that mirrors the FDA's three-tier approach. Manufacturers must obtain a Registro Sanitario before selling devices in Colombia. The process involves technical documentation, manufacturing quality evidence (typically ISO 13485 certification), and product-specific safety data.
INVIMA also conducts post-market surveillance, including adverse event reporting (tecnovigilancia) and facility inspections. The system is designed to ensure that devices on the Colombian market meet defined safety standards, though the depth of pre-market clinical review varies by device class.
Many devices used in top-tier Colombian hospitals are manufactured by the same global companies that supply US and European hospitals: Medtronic, Johnson and Johnson, Stryker, Smith and Nephew, Alcon, Zimmer Biomet. The device itself may be identical. What differs is which regulator reviewed and approved it for that market. Ask your surgeon: "What brand and model of implant will you use, and is it also FDA-cleared or CE-marked?"
COFEPRIS: Mexico's Regulator
COFEPRIS (Comision Federal para la Proteccion contra Riesgos Sanitarios) regulates medical devices in Mexico using a comparable risk-based classification. The registration process requires a technical dossier with safety and performance data, manufacturing quality evidence, and product labeling in Spanish.
Mexico participates in the Global Harmonization Working Party (GHWP), which aligns regulatory approaches across countries. In practice, COFEPRIS often recognizes FDA clearance or CE marking as part of the technical dossier, which can accelerate approval for devices already cleared in those markets.
CE Mark: The European Standard
CE marking is not a single regulatory body. It is a system where manufacturers demonstrate conformity with EU directives through assessment by independent Notified Bodies. The EU Medical Device Regulation (MDR), fully enforced since 2021, significantly tightened requirements for clinical evidence, post-market surveillance, and Notified Body scrutiny.
Under the MDR, higher-risk devices require clinical investigations or sufficient clinical evaluation data. Notified Bodies conduct unannounced audits of manufacturers. The regulation also introduced a Unique Device Identification (UDI) system for traceability.
What to Ask Before Your Procedure
- "What brand and model of device will be used?" Get the specific name, not a generic category.
- "Is this device also FDA-cleared or CE-marked?" Many internationally used devices carry multiple regulatory approvals.
- "How long has this device been on the market?" A device with 10 years of post-market data is different from one approved last year.
- "What is the implant warranty or guarantee?" Some manufacturers offer warranties that are honored internationally.
- "Will I receive the device serial number and lot number?" You need this for your medical records and for any future follow-up or recall notification.
If a facility cannot or will not tell you the specific brand and model of device being implanted, or if they use generic, unbranded devices without traceable regulatory registration, that is a significant concern regardless of the country. Legitimate facilities use traceable, registered devices and provide documentation.
Are implants used in Colombia FDA-approved?
Not necessarily. INVIMA is Colombia's regulator. Many devices are also FDA-cleared or CE-marked, but INVIMA approval is the legal requirement. Ask for the specific device brand and check its status.
What is INVIMA?
Colombia's equivalent of the FDA. It regulates medical devices, pharmaceuticals, food, and cosmetics with a risk-based classification system that mirrors the FDA's tiers.
Is CE Mark as rigorous as FDA approval?
Different frameworks. Under the EU MDR (2021), CE marking requirements have become significantly more stringent, with clinical evidence requirements and unannounced audits.
Related: Compare
Side-by-side treatment comparisons with the evidence, the trade-offs, and the chart that settles the question.
Read the ComparisonsNeed a Second Opinion on a System?
Tell us what procedure you are considering and which country you are looking at. We will send you the accreditation status, quality data, and an honest assessment.
Start on WhatsApp